elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q30397022-1F4C65C1-55FC-441C-9C09-C49FF8B15AAF
Q30397022-1F4C65C1-55FC-441C-9C09-C49FF8B15AAF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30397022-1F4C65C1-55FC-441C-9C09-C49FF8B15AAF
Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania.
P2860
Q30397022-1F4C65C1-55FC-441C-9C09-C49FF8B15AAF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30397022-1F4C65C1-55FC-441C-9C09-C49FF8B15AAF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8451315f7cfab50b8eaf2153baefe7994c20ad3c
P2860
A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.